208 related articles for article (PubMed ID: 38608537)
1. Structure-function of type I and III interferons.
de Weerd NA; Kurowska AK; Mendoza JL; Schreiber G
Curr Opin Immunol; 2024 Feb; 86():102413. PubMed ID: 38608537
[TBL] [Abstract][Full Text] [Related]
2. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
[TBL] [Abstract][Full Text] [Related]
3. Differential receptor subunit affinities of type I interferons govern differential signal activation.
Jaks E; Gavutis M; Uzé G; Martal J; Piehler J
J Mol Biol; 2007 Feb; 366(2):525-39. PubMed ID: 17174979
[TBL] [Abstract][Full Text] [Related]
4. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
5. The Role of Structure in the Biology of Interferon Signaling.
Walter MR
Front Immunol; 2020; 11():606489. PubMed ID: 33281831
[TBL] [Abstract][Full Text] [Related]
6. Shared receptor components but distinct complexes for alpha and beta interferons.
Lewerenz M; Mogensen KE; Uzé G
J Mol Biol; 1998 Sep; 282(3):585-99. PubMed ID: 9737924
[TBL] [Abstract][Full Text] [Related]
7. Herpes Simplex Virus 1 UL36USP Antagonizes Type I Interferon-Mediated Antiviral Innate Immunity.
Yuan H; You J; You H; Zheng C
J Virol; 2018 Oct; 92(19):. PubMed ID: 29997210
[TBL] [Abstract][Full Text] [Related]
8. The EM structure of a type I interferon-receptor complex reveals a novel mechanism for cytokine signaling.
Li Z; Strunk JJ; Lamken P; Piehler J; Walz T
J Mol Biol; 2008 Mar; 377(3):715-24. PubMed ID: 18252254
[TBL] [Abstract][Full Text] [Related]
9. IFNAR1 and IFNAR2 play distinct roles in initiating type I interferon-induced JAK-STAT signaling and activating STATs.
Shemesh M; Lochte S; Piehler J; Schreiber G
Sci Signal; 2021 Nov; 14(710):eabe4627. PubMed ID: 34813358
[TBL] [Abstract][Full Text] [Related]
10. Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control.
Andreakos E; Zanoni I; Galani IE
Curr Opin Immunol; 2019 Feb; 56():67-75. PubMed ID: 30399529
[TBL] [Abstract][Full Text] [Related]
11. Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway.
Meyts I; Casanova JL
Eur J Immunol; 2021 May; 51(5):1039-1061. PubMed ID: 33729549
[TBL] [Abstract][Full Text] [Related]
12. Structural linkage between ligand discrimination and receptor activation by type I interferons.
Thomas C; Moraga I; Levin D; Krutzik PO; Podoplelova Y; Trejo A; Lee C; Yarden G; Vleck SE; Glenn JS; Nolan GP; Piehler J; Schreiber G; Garcia KC
Cell; 2011 Aug; 146(4):621-32. PubMed ID: 21854986
[TBL] [Abstract][Full Text] [Related]
13. Type III interferon is a critical regulator of innate antifungal immunity.
Espinosa V; Dutta O; McElrath C; Du P; Chang YJ; Cicciarelli B; Pitler A; Whitehead I; Obar JJ; Durbin JE; Kotenko SV; Rivera A
Sci Immunol; 2017 Oct; 2(16):. PubMed ID: 28986419
[TBL] [Abstract][Full Text] [Related]
14. Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities.
Subramaniam PS; Khan SA; Pontzer CH; Johnson HM
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12270-4. PubMed ID: 8618883
[TBL] [Abstract][Full Text] [Related]
15. The human type I interferon receptor. Identification of the interferon beta-specific receptor-associated phosphoprotein.
Croze E; Russell-Harde D; Wagner TC; Pu H; Pfeffer LM; Perez HD
J Biol Chem; 1996 Dec; 271(52):33165-8. PubMed ID: 8969169
[TBL] [Abstract][Full Text] [Related]
16. Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers.
Lamken P; Lata S; Gavutis M; Piehler J
J Mol Biol; 2004 Jul; 341(1):303-18. PubMed ID: 15312780
[TBL] [Abstract][Full Text] [Related]
17. Membrane-proximal motifs encode differences in signaling strength between type I and III interferon receptors.
Mesev EV; Lin AE; Guare EG; Heller BL; Douam F; Adamson B; Toettcher JE; Ploss A
Sci Signal; 2023 Oct; 16(806):eadf5494. PubMed ID: 37816090
[TBL] [Abstract][Full Text] [Related]
18. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
Piehler J; Schreiber G
J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
[TBL] [Abstract][Full Text] [Related]
19. Pseudorabies Virus Inhibits Type I and Type III Interferon-Induced Signaling via Proteasomal Degradation of Janus Kinases.
Yin Y; Romero N; Favoreel HW
J Virol; 2021 Sep; 95(20):e0079321. PubMed ID: 34379505
[TBL] [Abstract][Full Text] [Related]
20. Novel type III interferons produce anti-tumor effects through multiple functions.
Li Q; Kawamura K; Tada Y; Shimada H; Hiroshima K; Tagawa M
Front Biosci (Landmark Ed); 2013 Jun; 18(3):909-18. PubMed ID: 23747856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
